Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Parambir Dulai

    TitleAssociate Physician
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address9500 Gilman Drive #0956
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Fumery M, Singh S, Dulai P, Gower-Rousseau C, Peyrin-Biroulet L, Sandborn WJ. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol. 2017 Jun 16. PMID: 28625817.
        View in: PubMed
      2. Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Dulai P, Caussy C, Bettencourt R, Highlander SK, Jones MB, Sirlin CB, Schnabl B, Brinkac L, Schork N, Chen CH, Brenner DA, Biggs W, Yooseph S, Venter JC, Nelson KE. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metab. 2017 May 02; 25(5):1054-1062.e5. PMID: 28467925.
        View in: PubMed
      3. Jairath V, Zou G, Parker CE, MacDonald JK, Mosli MH, AlAmeel T, Al Beshir M, AlMadi M, Al-Taweel T, Atkinson NS, Biswas S, Chapman TP, Dulai P, Glaire MA, Hoekman D, Kherad O, Koutsoumpas A, Minas E, Restellini S, Samaan MA, Khanna R, Levesque BG, D'Haens G, Sandborn WJ, Feagan BG. Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease. Aliment Pharmacol Ther. 2017 Feb 05. PMID: 28164348.
        View in: PubMed
      4. Dulai P, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, Stal P, Wong VW, Kechagias S, Hultcrantz R, Loomba R. Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease: Systematic Review and Meta-analysis. Hepatology. 2017 Jan 28. PMID: 28130788.
        View in: PubMed
      5. Hindryckx P, Novak G, Vande Casteele N, Laukens D, Parker C, Shackelton LM, Narula N, Khanna R, Dulai P, Levesque BG, Sandborn WJ, D'Haens G, Feagan BG, Jairath V. Review article: dose optimisation of infliximab for acute severe ulcerative colitis. Aliment Pharmacol Ther. 2017 Jan 11. PMID: 28074618.
        View in: PubMed
      6. Fumery M, Dulai P, Meirick P, Farrell AM, Ramamoorthy S, Sandborn WJ, Singh S. Systematic review with meta-analysis: recurrence of Crohn's disease after total colectomy with permanent ileostomy. Aliment Pharmacol Ther. 2016 Dec 08. PMID: 27928830.
        View in: PubMed
      7. Dulai P, Singh S, Marquez E, Khera R, Prokop LJ, Limburg PJ, Gupta S, Murad MH. Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis. BMJ. 2016 Dec 05; 355:i6188. PMID: 27919915.
        View in: PubMed
      8. Fumery M, Dulai P, Gupta S, Prokop LJ, Ramamoorthy S, Sandborn WJ, Singh S. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients with Ulcerative Colitis with Low-Grade Dysplasia: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2016 Dec 01. PMID: 27916678.
        View in: PubMed
      9. Singh S, Dulai P, Zarrinpar A, Ramamoorthy S, Sandborn WJ. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2016 Nov 30. PMID: 27899815.
        View in: PubMed
      10. Arulanandan A, Dulai P, Singh S, Sandborn WJ, Kalmaz D. Systematic review: Safety of balloon assisted enteroscopy in Crohn's disease. World J Gastroenterol. 2016 Oct 28; 22(40):8999-9011. PMID: 27833391.
        View in: PubMed
      11. Abraham C, Dulai P, Vermeire S, Sandborn WJ. Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases. Gastroenterology. 2016 Oct 22. PMID: 27780712.
        View in: PubMed
      12. Dulai P, Sandborn WJ, Gupta S. Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management. Cancer Prev Res (Phila). 2016 Dec; 9(12):887-894. PMID: 27679553.
        View in: PubMed
      13. Dulai P, Sandborn WJ. Next-Generation Therapeutics for Inflammatory Bowel Disease. Curr Gastroenterol Rep. 2016 Sep; 18(9):51. PMID: 27461274.
        View in: PubMed
      14. Dulai P, Singh S, Jiang X, Peerani F, Narula N, Chaudrey K, Whitehead D, Hudesman D, Lukin D, Swaminath A, Shmidt E, Wang S, Boland BS, Chang JT, Kane S, Siegel CA, Loftus EV, Sandborn WJ, Sands BE, Colombel JF. The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium. Am J Gastroenterol. 2016 Jun 14. PMID: 27296941.
        View in: PubMed
      15. Dulai P, Sirlin CB, Loomba R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. J Hepatol. 2016 Nov; 65(5):1006-1016. PMID: 27312947.
        View in: PubMed
      16. Khera R, Murad MH, Chandar AK, Dulai P, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. JAMA. 2016 Jun 14; 315(22):2424-34. PMID: 27299618.
        View in: PubMed
      17. Kim RG, Nguyen P, Bettencourt R, Dulai P, Haufe W, Hooker J, Minocha J, Valasek MA, Aryafar H, Brenner DA, Sirlin CB, Loomba R. Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study. Aliment Pharmacol Ther. 2016 Aug; 44(3):287-99. PMID: 27279429.
        View in: PubMed
      18. Dulai P, Singh S, Casteele NV, Boland BS, Sandborn WJ. How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 Apr; 22(4):998-1009. PMID: 26835982.
        View in: PubMed
      19. Agoston AT, Strauss AC, Dulai P, Hagen CE, Muzikansky A, Fudman DI, Abrams JA, Forcione DG, Jajoo K, Saltzman JR, Odze RD, Lauwers GY, Gordon SR, Lightdale CJ, Rothstein RI, Srivastava A. Predictors Of Treatment Failure After Radiofrequency Ablation For Intramucosal Adenocarcinoma in Barrett Esophagus: A Multi-institutional Retrospective Cohort Study. Am J Surg Pathol. 2016 Apr; 40(4):554-62. PMID: 26645729.
        View in: PubMed
      20. Jairath V, Zou G, Parker CE, Macdonald JK, Mosli MH, Khanna R, Shackelton LM, Vandervoort MK, AlAmeel T, Al Beshir M, AlMadi M, Al-Taweel T, Atkinson NS, Biswas S, Chapman TP, Dulai P, Glaire MA, Hoekman D, Koutsoumpas A, Minas E, Samaan MA, Travis S, D'Haens G, Levesque BG, Sandborn WJ, Feagan BG. Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis. J Crohns Colitis. 2016 May; 10(5):607-18. PMID: 26746169.
        View in: PubMed
      21. Siegel CA, Horton H, Siegel LS, Thompson KD, Mackenzie T, Stewart SK, Rice PW, Stempak JM, Dezfoli S, Haritunians T, Levy A, Baek M, Milgrom R, Dulai P, Targan SR, Silverberg MS, Dubinsky MC, McGovern DP. A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables. Aliment Pharmacol Ther. 2016 Jan; 43(2):262-71. PMID: 26567467.
        View in: PubMed
      22. Boland BS, Dulai P, Chang M, Sandborn WJ, Levesque BG. Pseudomonas Meningitis During Vedolizumab Therapy for Crohn's Disease. Am J Gastroenterol. 2015 Nov; 110(11):1631-2. PMID: 26618431.
        View in: PubMed
      23. Singh S, Ding NS, Mathis KL, Dulai P, Farrell AM, Pemberton JH, Hart AL, Sandborn WJ, Loftus EV. Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's disease. Aliment Pharmacol Ther. 2015 Oct; 42(7):783-92. PMID: 26264359.
        View in: PubMed
      24. Shatzel J, Dulai P, Harbin D, Cheung H, Reid TN, Kim J, James SL, Khine H, Batman S, Whyman J, Dickson RC, Ornstein DL. Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study. J Thromb Haemost. 2015 Jul; 13(7):1245-53. PMID: 25955079.
        View in: PubMed
      25. Dulai P, Levesque BG, Feagan BG, D'Haens G, Sandborn WJ. Assessment of mucosal healing in inflammatory bowel disease: review. Gastrointest Endosc. 2015 Aug; 82(2):246-55. PMID: 26005012.
        View in: PubMed
      26. Dulai P, Mosli M, Khanna R, Levesque BG, Sandborn WJ, Feagan BG. Vedolizumab for the treatment of moderately to severely active ulcerative colitis. Pharmacotherapy. 2015 Apr; 35(4):412-23. PMID: 25884529.
        View in: PubMed
      27. Strauss AC, Agoston AT, Dulai P, Srivastava A, Rothstein RI. Radiofrequency ablation for Barrett's-associated intramucosal carcinoma: a multi-center follow-up study. Surg Endosc. 2014 Dec; 28(12):3366-72. PMID: 24950726.
        View in: PubMed
      28. Dulai P, Siegel CA, Colombel JF, Sandborn WJ, Peyrin-Biroulet L. Systematic review: monotherapy with antitumour necrosis factor a agents versus combination therapy with an immunosuppressive for IBD. Gut. 2014 Dec; 63(12):1843-53. PMID: 24970900.
        View in: PubMed
      29. Dulai P, Siegel CA, Peyrin-Biroulet L. Anti-tumor necrosis factor-a monotherapy versus combination therapy with an immunomodulator in IBD. Gastroenterol Clin North Am. 2014 Sep; 43(3):441-56. PMID: 25110252.
        View in: PubMed
      30. Dulai P, Siegel CA. The risk of malignancy associated with the use of biological agents in patients with inflammatory bowel disease. Gastroenterol Clin North Am. 2014 Sep; 43(3):525-41. PMID: 25110257.
        View in: PubMed
      31. Dulai P, Gleeson MW, Taylor D, Holubar SD, Buckey JC, Siegel CA. Systematic review: The safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease. Aliment Pharmacol Ther. 2014 Jun; 39(11):1266-75. PMID: 24738651.
        View in: PubMed
      32. Dulai P, Thompson KD, Blunt HB, Dubinsky MC, Siegel CA. Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review. Clin Gastroenterol Hepatol. 2014 Sep; 12(9):1443-51; quiz e88-9. PMID: 24462626.
        View in: PubMed
      33. Dulai P, Siegel CA, Dubinsky MC. Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2013 Dec; 19(13):2927-36. PMID: 23867874; NIHMSID: NIHMS513839.
        View in: PubMed
      34. Dulai P, Gordon SR, Rothstein RI. Response. Gastrointest Endosc. 2013 Jul; 78(1):191. PMID: 23820416.
        View in: PubMed
      35. Dulai P, Pohl H, Levenick JM, Gordon SR, MacKenzie TA, Rothstein RI. Radiofrequency ablation for long- and ultralong-segment Barrett's esophagus: a comparative long-term follow-up study. Gastrointest Endosc. 2013 Apr; 77(4):534-41. PMID: 23290719.
        View in: PubMed
      36. Ghushe ND, Dulai P, Trus TL. Laparoendoscopic transgastric resection of a submucosal mass at the gastroesophageal junction. J Gastrointest Surg. 2012 Dec; 16(12):2321. PMID: 23054899.
        View in: PubMed
      37. Dulai P, Fisher ES, Rothstein RI. How may the transition to value-based payment influence gastroenterology: threat or opportunity? Clin Gastroenterol Hepatol. 2012 Jun; 10(6):609-11. PMID: 22624804.
        View in: PubMed
      38. Dulai P, Rothstein RI. Disseminated sarcoidosis presenting as granulomatous gastritis: a clinical review of the gastrointestinal and hepatic manifestations of sarcoidosis. J Clin Gastroenterol. 2012 May-Jun; 46(5):367-74. PMID: 22334224.
        View in: PubMed
      39. von Renteln D, Dulai P, Pohl H, Vassiliou MC, Rösch T, Rothstein RI. Endoscopic submucosal dissection with a flexible Maryland dissector: randomized comparison of mesna and saline solution for submucosal injection (with videos). Gastrointest Endosc. 2011 Oct; 74(4):906-11. PMID: 21802674.
        View in: PubMed